Whole cell-based vaccine against pancreatic cancer
This technology is a whole cell-based vaccine that boosts the patient’s immune system for a precision approach to pancreatic cancer treatment.
Greater potential for effectiveness than chemotherapyPatient-specific therapyCombinatorial design (i.e. dendritic cells, macrophages, whole cancer cells) activates complementary immune-response pathways against a full range of pancreatic cancer antibodiesLimits ability of cancer mutation to circumvent treatment
Vaccine for pancreatic cancerVaccine for other cancers with similar cell dynamicsFurther research into immune-cell response and whole-cell based immune-cell engineeringLibrary of various genotypes of immune cells presenting antigens from various whole cancer cellsCombination therapy for cancer in conjunction with chemotherapy and radiation
None
美國
